ArticleScientific reports2022

Baseline serum Krebs von den Lungen-6 as a biomarker for the disease progression in idiopathic pulmonary fibrosis.

Chiwook Chung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.